Page last updated: 2024-08-17

medroxyprogesterone acetate and Signs and Symptoms

medroxyprogesterone acetate has been researched along with Signs and Symptoms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19906 (46.15)18.7374
1990's7 (53.85)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mcdaniel, EB1
D'arcangues, C1
Ahmad, G; Rasul, A1
Hatcher, RA; Schnare, S1
Sparrow, M1
Kistner, RW1
Janaud, A1
Correu Azcona, S1
Jones, M1
Shrestha, A; Stoeckel, J; Tuladhar, JM1

Other Studies

13 other study(ies) available for medroxyprogesterone acetate and Signs and Symptoms

ArticleYear
Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
    IGCC news, 1980, Volume: 5, Issue:3

    Topics: Amenorrhea; Asia; Asia, Eastern; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Patient Acceptance of Health Care; Signs and Symptoms

1980
Once-a-month estrogen/progestogen injectables.
    Entre nous (Copenhagen, Denmark), 1991, Issue:19

    Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization

1991
Study of medroxyprogesterone: a long-acting injectable female contraceptive agent.
    Pakistan journal of medical research, 1970, Volume: 9, Issue:1

    Topics: Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Evaluation Studies as Topic; Family Planning Services; Genitalia; Genitalia, Female; Hemorrhage; Histology; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Parity; Physiology; Research; Signs and Symptoms; Urogenital System; Uterus

1970
Ask the experts: progestin-only contraceptives.
    Contraceptive technology update, 1993, Volume: 14, Issue:7

    Topics: Age Factors; Amenorrhea; Americas; Appetite; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Demography; Developed Countries; Disease; Drug Interactions; Family Planning Services; Hypersensitivity; Interviews as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Pharmaceutical Preparations; Physiology; Population; Population Characteristics; Progesterone Congeners; Research; Signs and Symptoms; Therapeutics; United States

1993
Contraception in the perimenopause.
    Current therapeutics, 1992, Volume: 33, Issue:12

    Topics: Coitus Interruptus; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Disease; Family Planning Services; Intrauterine Devices; Medroxyprogesterone Acetate; Menopause; Progesterone Congeners; Reproduction; Signs and Symptoms; Spermatocidal Agents; Sterilization, Reproductive

1992
Pretreatment counseling keeps patients on Depo.
    Contraceptive technology update, 1997, Volume: 18, Issue:10

    Topics: Ambulatory Care Facilities; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Economics; Family Planning Services; Health Planning; Health Services Needs and Demand; Hemorrhage; Injections; Medroxyprogesterone Acetate; Metrorrhagia; Organization and Administration; Physiology; Signs and Symptoms

1997
Newer synthetic progestins for the treatment of endometriosis.
    Progress in gynecology, 1970, Volume: 5

    Topics: Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Digestive System; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Injections; Lynestrenol; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Mestranol; Metrorrhagia; Nausea; Norethindrone; Norethynodrel; Pseudopregnancy; Reproduction; Signs and Symptoms; Thromboembolism; Vascular Diseases

1970
[Depo-provera as a long-term contraceptive].
    Contraception, fertilite, sexualite, 1974, Volume: 2, Issue:2

    Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Hemorrhage; Infertility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms

1974
Three-monthly Depo-Provera in Mexico.
    IPPF medical bulletin, 1977, Volume: 11, Issue:3

    Topics: Amenorrhea; Appetite; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Digestive System; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms

1977
Depo-Provera: just another contraceptive?
    Fertility and contraception, 1978, Volume: 2, Issue:2

    Topics: Amenorrhea; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; England; Europe; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Neoplasms; North America; Signs and Symptoms; United Kingdom; United States

1978
The KAP-gap in Nepal: reasons for non-use of contraception among couples with an unmet need for family planning.
    Asia-Pacific population journal, 1991, Volume: 6, Issue:1

    Topics: Asia; Birth Intervals; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Diagnosis; Disease; Endoscopy; Family Planning Services; Headache; Health; Health Knowledge, Attitudes, Practice; Hemorrhage; Laparoscopy; Medroxyprogesterone Acetate; Nausea; Nepal; Nutritional Physiological Phenomena; Physical Examination; Research; Sampling Studies; Signs and Symptoms; Sterilization, Reproductive; Surveys and Questionnaires; Vasectomy

1991
Medicolegal issues surrounding Depo-Provera easily overcome.
    Contraceptive technology update, 1992, Volume: 13, Issue:1

    Topics: Americas; Consumer Product Safety; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developed Countries; Disease; Drug Prescriptions; Family Planning Services; Health; Health Personnel; Health Planning; Hemorrhage; Informed Consent; Legislation as Topic; Medroxyprogesterone Acetate; North America; Organization and Administration; Physicians; Signs and Symptoms; United States

1992
Teens and Depo-Provera: a good match?
    Contraceptive technology update, 1995, Volume: 16, Issue:7

    Topics: Adolescent; Age Factors; Ambulatory Care Facilities; Americas; Appetite; Behavior; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Demography; Developed Countries; Diet; Disease; Family Planning Services; Health; Health Planning; Medroxyprogesterone Acetate; North America; Nutritional Physiological Phenomena; Organization and Administration; Physiology; Population; Population Characteristics; Risk-Taking; Sexual Behavior; Signs and Symptoms; United States

1995